alexa Mycobacterial Ribonucleotide Reductase

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Mycobacterial Ribonucleotide Reductase

Mycobacterium is the genus of actinobacteria, consisting of more than 100 species . The genus includes several pathogenic species viz, Mycobacterium tuberculosis causing tuberculosis and Mycobacterium leprae causing leprosy in humans. M. tuberculosis exhibits extraordinary capabilities to subvert and to resist the bactericidal response of their infected host. These capabilities led the bacillus to colonize one third of the world’s population and nearly 1.4 million people are killed annually. The emergence of drug resistance strains is a serious problem for TB control programmes

Citation: Mohanty PS, Naaz F, Singh P, Chauhan DS, Gupta UD, et al. (2015) Molecular Characterization of Mycobacterial Ribonucleotide Reductase (RNR) and its Implication as a Novel Drug Target. Bioenergetics 4:129

Source: https://www.omicsonline.org/open-access/molecular-characterization-of-mycobacterial-ribonucleotide-reductasernr-and-its-implication-as-a-novel-drug-target-2167-7662-1000129.php?aid=65348

 

 

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords